About Animal Parasiticides
Veterinary parasiticides or antiparasitics are products that kill parasites that infest livestock, pets, and other animals. The global animal parasiticides market is expected to grow at a moderate pace driven by the rise in demand for animal proteins and the increased focus on food safety. The increase in animal population will also help boost market growth. Bayer HealthCare, Elanco, Merial, Merck Animal Health, and Zoetis are the major vendors in the market. These vendors offer a wide portfolio of products in various segments such as animal diagnostics, animal vaccines, animal pharmaceuticals, and animal feed additives. These products are intended for use in companion animals and livestock. These products have active ingredients that kill or inhibit growth and a series of non-active ingredients such as stabilizers and solvents.
Technavio’s analysts forecast the global animal parasiticides market to grow at a CAGR of 5.87% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global animal parasiticides market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Animal Parasiticides Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Bayer HealthCare
• Elanco
• Merck Animal Health
• Merial
• Zoetis
Other prominent vendors
• Animal Medics
• Biogénesis Bagó
• Bio-Vet
• Boehringer Ingelheim
• Ceva Santé Animale
• Dechra Pharmaceuticals
• ECO Animal Health
• Huvepharma
• Indian Immunologicals
• Lillidale Animal Health
• Mobedco-Vet (The Arab Pesticides & Veterinary Drugs)
• Neogen
• Norbrook
• Orion
• Phibro Animal Health
• Vétoquinol
• Virbac
• Vitafor
Market driver
• Rise in incidences of zoonotic diseases.
• For a full, detailed list, view our report
Market challenge
• Lengthy regulatory approval process.
• For a full, detailed list, view our report
Market trend
• Vertical integration in livestock industry.
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Key market highlights
PART 05: Veterinary drug approval process
• NADAs and supplements
• ANADAs and supplements
• CNADAs
PART 06: Market Landscape
• Market overview
• Five forces analysis
PART 07: Market segmentation by type of animals
PART 08: Market segmentation by product category
• Ectoparasiticides
• Endoparasiticides
• Endectocides
PART 09: Geographical segmentation
• Parasiticides market in Americas
• Parasiticides market in EMEA
• Parasiticides market in APAC
PART 10: Decision framework
PART 11: Drivers and challenges
• Market drivers
• Impact of drivers on key customer segments
• Market challenges
• Impact of challenges on key customer segments
PART 12: Market trends
• Vertical integration in livestock industry
• Increase in R&D activities
• Industry-academia collaborations
PART 13: Vendor Landscape
• Competitive scenario
• Other prominent vendors
PART 14: Key vendor analysis
PART 15: Appendix
• List of abbreviations
List of Exhibits
Exhibit 01: Parameters for FDA approval
Exhibit 02: Overview of global animal parasiticides market
Exhibit 03: Factors influencing global animal parasiticides market 2016
Exhibit 04: Global animal parasiticides market snapshot: Developed and emerging markets 2016
Exhibit 05: Global animal parasiticides market 2017-2021($ millions)
Exhibit 06: Five forces analysis
Exhibit 07: Global animal parasiticides market segments by type of animals
Exhibit 08: Global animal parasiticides market by product category 2016
Exhibit 09: Global ectoparasiticides market 2016-2021 ($ millions)
Exhibit 10: Global endoparasiticides market 2016-2021 ($ millions)
Exhibit 11: Global endectocides market 2016-2021 ($ millions)
Exhibit 12: Segmentation of global animal parasiticides market based on geography 2016 and 2021
Exhibit 13: Global animal parasiticides market revenue by geography 2016-2021 ($ millions)
Exhibit 14: Market scenario in Americas
Exhibit 15: Animal parasiticides market in Americas 2016-2021 ($ millions)
Exhibit 16: Market scenario in EMEA
Exhibit 17: Animal parasiticides market in EMEA ($ millions)
Exhibit 18: Market scenario in APAC
Exhibit 19: Animal Parasiticides market in APAC ($ millions)
Exhibit 20: Impact of drivers and challenges in global animal parasiticides market
Exhibit 21: Impact of drivers
Exhibit 22: Impact of challenges
Exhibit 23: Strategic success factors of companies in global animal parasiticides market
Exhibit 24: Bayer HealthCare: Key highlights
Exhibit 25: Bayer HealthCare: Strength assessment
Exhibit 26: Bayer HealthCare: Strategy assessment
Exhibit 27: Bayer HealthCare: Opportunity assessment
Exhibit 28: Elanco: Key highlights
Exhibit 29: Elanco: Strength assessment
Exhibit 30: Elanco: Strategy assessment
Exhibit 31: Elanco: Opportunity assessment
Exhibit 32: Merck Animal Health: Key highlights
Exhibit 33: Merck Animal Health: Strength assessment
Exhibit 34: Merck Animal Health: Strategy assessment
Exhibit 35: Merck Animal Health: Opportunity assessment
Exhibit 36: Merial: Key highlights
Exhibit 37: Merial: Strength assessment
Exhibit 38: Merial: Strategy assessment
Exhibit 39: Merial: Opportunity assessment
Exhibit 40: Zoetis: Key highlights
Exhibit 41: Zoetis: Strength assessment
Exhibit 42: Zoetis: Strategy assessment
Exhibit 43: Zoetis: Opportunity assessment
